Innovation in 3D in vitro oncology
18 Apr 2024Insphero offers advanced 3D in vitro technology for immuno-oncology screening, and presents the 3D InSight™ Tumor Microtissue in the assessment of Antibody-Drug Conjugates (ADCs) efficacy and penetration depth. InSphero further highlights the product's capabilities including the evaluation of various therapeutic modalities, such as antibody-based therapeutics, with confidence, covering mechanisms of action, immune cell engagement, off-target effects, and more.
Related Products
Request Quote for All Products
3D InSight™ Human Liver Microtissues
InSpheroDiscover the 3D InSight™ Human Liver Microtissues: the gold standard for Hepatotoxic screening. Pharma-validated co-culture models offer 2x higher DILI prediction sensitivity than 2D hepatocytes. Features pooled PHH from male/female donors co-cultured with Kupffer cells and LECs, 28-day viability, in 96-well format. Includes 50mL 3D InSight™ Liver Maintenance Medium. Check the bi-weekly production schedule online.